B-4 | Clinical Outcomes of Patients with Transient Loss of Pulsatility During Hemodynamically Supported High Risk PCI
Mir B. Basir(Henry Ford Hospital), William W. O’Neill(Henry Ford Health System), Katherine Kunkel(Piedmont Atlanta Hospital), Mohammad Alqarqaz(Henry Ford Hospital), Akshay Khandelwal(Henry Ford Health System), Daniel Burkhoff(Columbia University Irving Medical Center), Gregg W. Stone(Cardiovascular Institute of the South), Alejandro Lemor(Jackson Memorial Hospital), Duane S. Pinto(Beth Israel Deaconess Medical Center), Jeffrey W. Moses(Good Samaritan University Hospital), Amir Kaki, Khaldoon Alaswad(Ford Motor Company (United States)), Michael Megaly(St. John Medical Center), Sanjog Kalra(University Health Network), Dana Frantz Bentley(Abiomed (United States)), Elise Jortberg(Abiomed (United States))
Journal of the Society for Cardiovascular Angiography & Interventions
May 1, 2022
Cited by 1
Related Papers
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k
A Controlled Trial of Renal Denervation for Resistant Hypertension
|New England Journal of Medicine|2014|2.2k
Bivalirudin for Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2006|1.5k
Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis
|The Lancet|2007|1.4k
A Randomized Trial of Immediate versus Delayed Elective Angioplasty after Intravenous Tissue Plasminogen Activator in Acute Myocardial Infarction
|New England Journal of Medicine|1987|945